When the COVID-19 pandemic hit in March 2020, we listened to the challenges and concerns of our clients. In response, we launched a comprehensive solution to ensure that their workplaces were COVID-19 safe.
Safeguard your workforce while maintaining productivity.
Our COVID-19 solution integrates guidelines from both the CDC and OSHA into an overall workplace surveillance and response plan to limit the possibility of workplace COVID-19 transmission among workers. Our COVID-19 solution integrates with your existing health and safety protocols.
The COVID-19 solution integrates guidelines from both the CDC and OSHA into an overall workplace surveillance and response plan. Our team, led by pandemic response expert, Dr. William Lang, has created this program to keep your employees safe and healthy while ensuring maximum efficiency.
The Benefits of our COVID-19 Program
Lower risk of transmission among employees
Day-to-day operational stability
Reduced workforce downtime
Confident, more engaged workforce
Diminished COVID-related claims
Decreased risk of litigation
The positive impact of our pandemic safety program is clear.
of employees screened daily
managed potential exposures
man-days of work saved (so far!)
Scott Gerard, VP of Safety, Moss Construction
“Our partnership with JobSiteCare has been tremendously successful in keeping our team members healthy and our job sites open without interruption and no COVID-19 related claims.”
COVID-19 Blog & Updates
There was a large study announced this week from Australia addressing the survival of the virus on various surfaces. They found the virus could be recovered over a longer duration of time than previously thought, but also found that there was generally more rapid decay.
In the US, current levels are at about 75% of the peak seen in mid-July, but they are still steadily rising…not as fast as of late June and early July, but there is no evidence of a new peak.
Most of the news of the last week has surrounded President Trump’s diagnosis and apparent rapid recovery from COVID-19. As of right now, we do not know where the infection occurred.
COVID-19 case rates are once again on the increase in much of the world. Fortunately, these increasing rates do not apply to death rates, which continue to decrease in most locations.
This week Dr. Fauci clarified that he fully expects that anyone who wants to be vaccinated will be fully vaccinated by April of next year or roughly 6-7 months from now.
As of today, trials of the AstraZeneca/Oxford University vaccine have restarted in all participating countries except the US. This keeps all 3 major vaccine trials on track for data analysis some time next month.
AstraZeneca working in conjunction with the University of Oxford in the United Kingdom had a single test subject who developed a significant medical issue at some point after being given the immunization.
The biggest news this week is that both Dr. Stephen Hahn, Commissioner of the FDA, and Dr. Tony Fauci of the NIH both said that a limited Emergency Use Authorization for at least one of the vaccines could be issued as early as late October or early November.
Many of us are beginning to get a sense that we have fallen into a COVID-19 rhythm. That is both good and bad. The good is that people understand the basic concepts of risks – the risk of infection versus the risk of serious disease.
Subscribe to Our Newsletter